2022 SD_logo_tag_vert_RGB
Liberty16 and SalivaDirect

Easier and more accessible testing for SARS-CoV-2 (COVID-19)

Ubiquitome has partnered with The SalivaDirect Initiative at Yale School of Public Health to enhance public access to COVID-19 testing, with United States Food and Drug Administration (FDA) emergency use authorization (EUA) of the combination of SalivaDirect™ with Ubiquitome’s Liberty16 mobile real time-PCR.

In Yale School of Public Health testing the Liberty16 displayed performance similar to large, lab-bound instruments.

Proteinase K Primer/Probe RT-qPCR kit RT-qPCR instrument LOD Positive replicates Mean Ct value (SD)
Thermo IDT NEB Luna (2x) Agilent AriaMX 6 copies/μL 100% (20/20) 30.3 (0.4)
Thermo Eurofins NEB Luna (2x) Liberty16 12 copies/μL 100% (20/20) 35.18 (0.7)
Thermo IDT NEB Luna (2x) CFX384 Touch 6 copies/μL 100% (20/20) 36.25 (0.4)

Liberty16 Workplace Surveillance Testing for COVID-19

Now available for small and medium sized workplaces, with affordable on-site gold standard PCR testing to keep costs down, productivity up and your staff COVID safe.


Recent news

Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests
19 December, 2022

NIH RADx winner’s next gen Liberty16 Pro gets EUA Auckland, December 19, 2022: Ubiquitome’s next generation real time PC...

Lib16 with app@1920x
The Liberty 16

When small becomes big

Stay ahead of the curve with the mobile, real-time system PCR that fits in the palm of your hand.

An app is also available for your iPhone





Speed to result

"Costly instruments for real-time PCR analysis often stand in the way of equitable access for under resourced communities and countries and sustainability of testing systems"

Dr Anne Wyllie, Yale School of Public Health (on why they partnered with Ubiquitome)

Ubiquitome’s world class team is changing how the world accesses and shares genomic information.

About us